The Stem Cell & Xenograft Core (SCXC) - RRID: SCR_010035
The Stem Cell and Xenograft Core (SCXC) is a comprehensive resource laboratory and was established at the Perelman School of Medicine in 2008. The mission of the Core is to provide Investigators with a high-quality, cost-effective, and comprehensive resource to promote basic and translational research in the areas of cancer biology, infectious disease, immunotherapy, stem cell biology, and regenerative medicine.
We offer services centered around 2 components: (1) An extensive repository of live and fully annotated cells from adult patients with hematologic malignancies (AML, ALL, CLL, MPN, MDS), and hematopoietic stem/progenitor cells from healthy donors. (2) A full array of in vivo services and xenograft models (PDX, humanized immune system), in a dedicated BSL-2 barrier space equipped with optical imaging.
The SCXC remains unique amongst peer institutions with regards to the scopes of research, its scale, and its range of services.
Special Announcements
SCXC Suite training on the first and third Wednesday of the month at 2:00 p.m. Sign up for training through Knowledge Link.
From the Winter 2022 Biomedical Research Core Facilities Newsletter:
- Congratulations to David Schultz (High Throughput Screening Core Facility) and Andrea Stout (CDB Microscopy Core Facility) for the 2022 Core Director Awards!
- Cores Day 2023 will be back in person in the Fall and you can review Cores’ presentations from last year here.
- Authors are encouraged to acknowledge PSOM core facilities via Research Resource Identifiers (RRIDs). Research Resource Identifiers are ID numbers assigned to help researchers cite key resources (including core facilities), in biomedical literature. Usage of RRIDS will help the School track the impact of core facilities and serve to highlight the important work done by cores.
The Stem Cell and Xenograft Core RRID is RRID:SCR_010035.
You can find the Winter 2022 Biomedical Research Core Facilities Newsletter here.
The Stem Cell and Xenograft Core was highlighted in the Fall 2022 Core Newsletter! If you would like to learn more, please read about it here.